Mesothelioma Treatment News

A new mesothelioma test, approved in December 2008, faced use over 2,000 times in the Philadelphia, Pennsylvania lab of Rosetta Genomics. At its approval, the miRview meso test began to be distributed to the public in both Israel and Turkey and on a commercial basis throughout the United States. ThemiRview
Read the full story

A new treatment option has been studied at the University of Pennsylvania School of Medicine and the Nation Cancer Institute (NCI) that showed initial promise in its effectiveness on mesothelioma tumors in mice. Human studies on the therapy await further animal testing, but it could prove to be alifesaver
Read the full story

A Phase II SBIR grant of $1.88 million was offered to ZenBio, Inc., to commercialize human peritoneal mesothelial cells. With the grant money, the company will further study the applications and commercialization potential for these cells in research for cancer, type 2 diabetes, and obesity. Mesothelioma isa
Read the full story

The Food and Drug Administration (FDA) has recommended that Alfacell have its drug ONCONASE undergo one more clinical trial before having its rolling New Drug Application (NDA) submitted. The drug is used to treat those with unresectable malignant mesothelioma (UMM) who have failed at least one other chemotherapy treatmentin
Read the full story

A $12 million asbestos institute at Sydney's Concord Hospital is the first of its kind in the world. Named for the late Bernie Banton, the research center was opened on January 21, 2009, by Prime Minister Kevin Rudd, who has pledged $5 million to go to the facility. Bernie Bantonwas
Read the full story

oncologist reviewed content and asbestos exposure 101

Sokolove Law 24 Hour Promise

If we think that a mesothelioma lawyer can move forward with your case, we'll begin immediately - at no cost to you.